Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Open-Label Extension PLS240
DRUG
2 trials
Sponsors
Pathalys Pharma
Conditions
End Stage Kidney Disease
End-stage Kidney Disease (ESKD)
Secondary Hyperparathyroidism
Phase 3
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
Completed
NCT05832931
Pathalys Pharma
End-stage Kidney Disease (ESKD), Secondary Hyperparathyroidism
Start: 2023-04-28
End: 2025-07-28
Updated: 2025-09-09
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
Completed
NCT05836220
Pathalys Pharma
End Stage Kidney Disease, Secondary Hyperparathyroidism
Start: 2023-05-15
End: 2025-08-05
Updated: 2025-09-09